It’s no secret that I am fascinated by the millennials. They represent a demographic that has defied what we have deemed to be normal. There are both pros and cons to that fact, but as the millennials are getting ready to take the economic spotlight, they have become a NexGen mega-trend we cannot afford to miss. In order to uncover the most profitable opportunities here, we have to think like a millennial. Lucky for you, I tend to surround myself with millennials in both my work and personal life, and I’ve also done years of research on this elusive group of individuals.

A lot of the NexGen innovations and mega-trends we follow are really cool, from self-driving cars to augmented reality to washing machines that text you when the laundry is done. They can and do change the way we live, but when it comes to truly changing lives, nothing compares with the excitement and potential of NexGen medicine. The area that seems to hold the most potential is gene therapy, and it is one of the hottest trends in medicine. Efforts so far have been focused mostly on cures for certain types of cancer. I believe that gene therapy has the best shot right now of a cure.

While it seemed like the broad market volatility took down every stock in its wake, there were actually a few that managed to sidestep the carnage. And believe it or not, Twitter (TWTR), a stock that has largely lagged its peers since going public in late 2013, was one of the few technology companies that accomplished that feat. A lot of that has to do with TWTR reporting its first-ever quarterly profit on February 8. The stock gapped higher as a result, rallying as much as 30% before closing the day up 12% and at its best level since 2015.